AKT1 and Glucose intolerance: Thus, short-term αActRIIA/IIB treatment markedly enhanced muscle insulin-stimulated glucose uptake independent of AKT-TBC1D4 muscle insulin signaling but paradoxically elevated blood glucose and induced glucose intolerance.